44.13
price down icon6.92%   -3.28
after-market Dopo l'orario di chiusura: 43.99 -0.14 -0.32%
loading
Precedente Chiudi:
$47.41
Aprire:
$45.7
Volume 24 ore:
2.41M
Relative Volume:
1.07
Capitalizzazione di mercato:
$3.64B
Reddito:
-
Utile/perdita netta:
$-275.16M
Rapporto P/E:
-11.34
EPS:
-3.89
Flusso di cassa netto:
$-221.15M
1 W Prestazione:
-9.03%
1M Prestazione:
-23.60%
6M Prestazione:
+37.73%
1 anno Prestazione:
-10.34%
Intervallo 1D:
Value
$43.76
$46.00
Intervallo di 1 settimana:
Value
$43.76
$48.62
Portata 52W:
Value
$28.21
$62.00

Springworks Therapeutics Inc Stock (SWTX) Company Profile

Name
Nome
Springworks Therapeutics Inc
Name
Telefono
203-883-9490
Name
Indirizzo
100 WASHINGTON BOULEVARD, STAMFORD, CT
Name
Dipendente
0
Name
Cinguettio
@springworkstx
Name
Prossima data di guadagno
2024-11-12
Name
Ultimi documenti SEC
Name
SWTX's Discussions on Twitter

Confronta SWTX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
SWTX
Springworks Therapeutics Inc
44.13 3.64B 0 -275.16M -221.15M -3.89
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Springworks Therapeutics Inc Stock (SWTX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-11-20 Iniziato Evercore ISI Outperform
2024-02-05 Iniziato Guggenheim Buy
2022-12-01 Iniziato BofA Securities Buy
2021-01-19 Reiterato H.C. Wainwright Buy
2020-10-29 Reiterato H.C. Wainwright Buy
2020-05-05 Iniziato Barclays Overweight
2020-03-19 Aggiornamento H.C. Wainwright Neutral → Buy
2020-03-04 Downgrade H.C. Wainwright Buy → Neutral
2020-01-21 Reiterato H.C. Wainwright Buy
2019-12-04 Iniziato H.C. Wainwright Buy
2019-10-08 Iniziato Cowen Outperform
2019-10-08 Iniziato Goldman Buy
2019-10-08 Iniziato JP Morgan Overweight
2019-10-08 Iniziato Wedbush Outperform
Mostra tutto

Springworks Therapeutics Inc Borsa (SWTX) Ultime notizie

pulisher
02:24 AM

BIT Capital GmbH Increases Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

02:24 AM
pulisher
11:59 AM

Segall Bryant & Hamill LLC Acquires 58,522 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

11:59 AM
pulisher
Mar 29, 2025

Cibc World Markets Corp Takes $232,000 Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

Mar 29, 2025
pulisher
Mar 28, 2025

SpringWorks Therapeutics (NASDAQ:SWTX) Stock Price Down 2.5%Time to Sell? - MarketBeat

Mar 28, 2025
pulisher
Mar 25, 2025

SpringWorks Therapeutics Target of Unusually Large Options Trading (NASDAQ:SWTX) - MarketBeat

Mar 25, 2025
pulisher
Mar 24, 2025

Neurofibromatosis Type 2 Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Recursion Pharma, Vivace Therapeutics, Healx Limited, SpringWorks Therapeutics - Barchart

Mar 24, 2025
pulisher
Mar 24, 2025

Neurofibromatosis Type 2 Pipeline 2025: Key Companies, MOA, - openPR

Mar 24, 2025
pulisher
Mar 24, 2025

Raymond James Financial Inc. Invests $10.53 Million in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

Mar 24, 2025
pulisher
Mar 23, 2025

46,895 Shares in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Purchased by Platinum Investment Management Ltd. - MarketBeat

Mar 23, 2025
pulisher
Mar 21, 2025

SpringWorks Therapeutics (NASDAQ:SWTX) Shares Down 4.8%Should You Sell? - MarketBeat

Mar 21, 2025
pulisher
Mar 21, 2025

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Short Interest Update - MarketBeat

Mar 21, 2025
pulisher
Mar 20, 2025

Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week - MSN

Mar 20, 2025
pulisher
Mar 19, 2025

FDA’s new and supplemental approvals in February - BioCentury

Mar 19, 2025
pulisher
Mar 19, 2025

Bank of New York Mellon Corp Sells 30,986 Shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

Mar 19, 2025
pulisher
Mar 18, 2025

This Is What Whales Are Betting On SpringWorks Therapeutics - Benzinga

Mar 18, 2025
pulisher
Mar 17, 2025

SpringWorks Therapeutics and Jewelry Designer Jennifer Fisher Te - GuruFocus.com

Mar 17, 2025
pulisher
Mar 15, 2025

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Shares Sold by Victory Capital Management Inc. - MarketBeat

Mar 15, 2025
pulisher
Mar 13, 2025

High Growth Tech Stocks In The US Market March 2025 - Simply Wall St

Mar 13, 2025
pulisher
Mar 13, 2025

How To Trade (SWTX) - Stock Traders Daily

Mar 13, 2025
pulisher
Mar 12, 2025

SpringWorks Therapeutics Inc (SWTX) Q4 2024 Earnings Report Prev - GuruFocus.com

Mar 12, 2025
pulisher
Mar 12, 2025

SpringWorks Shares Rise More Than 30% in 3 Months: Here's Why - TradingView

Mar 12, 2025
pulisher
Mar 12, 2025

SpringWorks Therapeutics, Inc.'s (NASDAQ:SWTX) Shares Climb 26% But Its Business Is Yet to Catch Up - Simply Wall St

Mar 12, 2025
pulisher
Mar 12, 2025

Victory Capital Management Inc. Reduces Stock Position in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

SpringWorks Therapeutics: Promising Launches, Expanding Pipeline, And M&A Buzz - Seeking Alpha

Mar 11, 2025
pulisher
Mar 11, 2025

Candriam S.C.A. Cuts Stake in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) - MarketBeat

Mar 11, 2025
pulisher
Mar 11, 2025

Traders Buy Large Volume of Call Options on SpringWorks Therapeutics (NASDAQ:SWTX) - MarketBeat

Mar 11, 2025
pulisher
Mar 10, 2025

SpringWorks Therapeutics (NASDAQ:SWTX) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat

Mar 10, 2025
pulisher
Mar 10, 2025

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) CEO Saqib Islam Sells 49,000 Shares - MarketBeat

Mar 10, 2025
pulisher
Mar 10, 2025

SpringWorks Therapeutics Leads Biotech Pack In Weekly Retail Follower Surge: What's Fueling Interest? - MSN

Mar 10, 2025
pulisher
Mar 10, 2025

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) COO Badreddin Edris Sells 20,000 Shares - MarketBeat

Mar 10, 2025
pulisher
Mar 08, 2025

SpringWorks Therapeutics (NASDAQ:SWTX) Shares Down 6%Should You Sell? - MarketBeat

Mar 08, 2025
pulisher
Mar 08, 2025

SpringWorks gains after cancelling from investor conference - MSN

Mar 08, 2025
pulisher
Mar 07, 2025

Check Out What Whales Are Doing With SWTX - Benzinga

Mar 07, 2025

Springworks Therapeutics Inc Azioni (SWTX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
Capitalizzazione:     |  Volume (24 ore):